Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India
· Delayed Price · Currency is INR 681.05
-19.10 (-2.73%)
At close: Mar 9, 2026
Aarti Pharmalabs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Market Capitalization | 61,742 | 67,908 | 39,418 | 24,999 | - | - | Upgrade
|
| Market Cap Growth | -7.46% | 72.28% | 57.68% | - | - | - | Upgrade
|
| Enterprise Value | 67,934 | 70,778 | 40,892 | 26,947 | - | - | Upgrade
|
| Last Close Price | 681.05 | 745.65 | 430.69 | 272.10 | - | - | Upgrade
|
| PE Ratio | 28.91 | 24.93 | 18.17 | 12.92 | - | - | Upgrade
|
| PS Ratio | 3.43 | 3.21 | 2.13 | 1.29 | - | - | Upgrade
|
| PB Ratio | 3.02 | 3.41 | 2.24 | 1.60 | - | - | Upgrade
|
| P/TBV Ratio | 3.20 | 3.59 | 2.35 | 1.65 | - | - | Upgrade
|
| P/FCF Ratio | - | - | 64.89 | 16.89 | - | - | Upgrade
|
| P/OCF Ratio | - | 20.48 | 18.22 | 9.99 | - | - | Upgrade
|
| EV/Sales Ratio | 3.77 | 3.35 | 2.21 | 1.39 | - | - | Upgrade
|
| EV/EBITDA Ratio | 16.58 | 15.59 | 10.75 | 7.88 | - | - | Upgrade
|
| EV/EBIT Ratio | 21.14 | 18.75 | 13.07 | 9.64 | - | - | Upgrade
|
| EV/FCF Ratio | - | - | 67.31 | 18.21 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.21 | 0.16 | 0.14 | 0.25 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 1.66 | 0.92 | 0.74 | 0.63 | 1.65 | - | Upgrade
|
| Debt / FCF Ratio | - | - | 4.70 | 1.46 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.30 | 0.18 | 0.11 | 0.10 | 0.19 | -1.02 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.54 | 0.80 | 0.50 | 0.45 | 1.25 | - | Upgrade
|
| Net Debt / FCF Ratio | - | -5.18 | 3.14 | 1.03 | -1.40 | - | Upgrade
|
| Asset Turnover | - | 0.77 | 0.77 | 0.91 | 1.18 | - | Upgrade
|
| Inventory Turnover | - | 1.91 | 1.70 | 2.24 | - | - | Upgrade
|
| Quick Ratio | - | 0.98 | 0.90 | 0.86 | 0.80 | 11.42 | Upgrade
|
| Current Ratio | - | 2.01 | 1.94 | 1.94 | 1.77 | 11.42 | Upgrade
|
| Return on Equity (ROE) | - | 14.54% | 13.08% | 13.14% | 17.63% | -2.00% | Upgrade
|
| Return on Assets (ROA) | - | 8.60% | 8.10% | 8.16% | 10.10% | -1.15% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.08% | 13.25% | 12.34% | 12.36% | 15.77% | - | Upgrade
|
| Return on Capital Employed (ROCE) | - | 16.80% | 16.60% | 17.00% | 11.30% | -2.00% | Upgrade
|
| Earnings Yield | 3.46% | 4.01% | 5.50% | 7.74% | - | - | Upgrade
|
| FCF Yield | - | -1.04% | 1.54% | 5.92% | - | - | Upgrade
|
| Dividend Yield | 0.71% | 0.67% | 0.70% | 0.73% | - | - | Upgrade
|
| Payout Ratio | - | 11.64% | 8.36% | 9.37% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.10% | -0.07% | -0.01% | - | -36150.40% | - | Upgrade
|
| Total Shareholder Return | 0.61% | 0.60% | 0.69% | 0.73% | -36150.40% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.